PRKCA and pancreatic neoplasm: For example, miR-216a overexpression can promote breast cancer cell apoptosis by targeting protein kinase C alpha (PKCα) (Cui et al., 2019) and increase cell apoptosis in response to gemcitabine in the pancreatic cancer cells (Zhang et al., 2017).